Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Research & Development (2023 - 2026)

Camp4 Therapeutics' Research & Development history spans 3 years, with the latest figure at $8.4 million for Q4 2025.

  • On a quarterly basis, Research & Development fell 16.4% to $8.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $38.2 million, a 1.61% decrease, with the full-year FY2025 number at $38.2 million, down 1.58% from a year prior.
  • Research & Development hit $8.4 million in Q4 2025 for Camp4 Therapeutics, down from $9.4 million in the prior quarter.
  • Over the last five years, Research & Development for CAMP hit a ceiling of $10.7 million in Q4 2023 and a floor of $8.4 million in Q4 2025.
  • Historically, Research & Development has averaged $9.8 million across 3 years, with a median of $9.8 million in 2023.
  • The widest YoY moves for Research & Development: up 10.16% in 2025, down 16.4% in 2025.
  • Tracing CAMP's Research & Development over 3 years: stood at $10.7 million in 2023, then decreased by 6.24% to $10.0 million in 2024, then fell by 16.4% to $8.4 million in 2025.
  • Business Quant data shows Research & Development for CAMP at $8.4 million in Q4 2025, $9.4 million in Q3 2025, and $10.3 million in Q2 2025.